bimakalim has been researched along with cromakalim in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 13 (92.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, R; Gericke, R | 1 |
| Armstrong, JM; Barras, M; Hicks, PE; Lawson, K; Martin, DJ; Zazzi-Sudriez, E | 1 |
| Bertrand, JP; Gautier, P; Guiraudou, P | 1 |
| Haeusler, G | 1 |
| Franke, C; Hatt, H; Quasthoff, S; Richter-Turtur, M | 1 |
| Grafe, P; Lehmann-Horn, F; Quasthoff, S; Spittelmeister, W; Spuler, A | 1 |
| Doussau, MP; Gautier, P; Giudicelli, JF; Mulder, P; Richer, C | 1 |
| Doussau, MP; Giudicelli, JF; Mulder, P; Richer, C | 1 |
| Parsons, AA; Schilling, L; Wahl, M | 1 |
| Grover, GJ | 1 |
| Cavero, I; Premmereur, J | 1 |
| Gericke, R; Harting, J; Lues, I; Schittenhelm, C | 1 |
| Arch, JR; Buckle, DR; Fenwick, AE; Houge-Frydrych, CS; Pinto, IL; Smith, DG; Taylor, SG; Tedder, JM | 1 |
| Andres, H; Bray, K; Manley, PW; Quast, U | 1 |
2 review(s) available for bimakalim and cromakalim
| Article | Year |
|---|---|
K(+)-channel openers: new antihypertensive drugs?
Topics: Antihypertensive Agents; Benzopyrans; Cromakalim; Dihydropyridines; Guanidines; Hemodynamics; Humans; Hypertension; Molecular Structure; Pinacidil; Potassium Channels; Pyrroles | 1990 |
Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dihydropyridines; Disease Models, Animal; Dogs; Guanidines; Guinea Pigs; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Rats; Vasodilator Agents | 1994 |
12 other study(ies) available for bimakalim and cromakalim
| Article | Year |
|---|---|
Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Chemical Phenomena; Chemistry; Dihydropyridines; Potassium Channels; Rats; Rats, Inbred SHR; Structure-Activity Relationship | 1990 |
Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Topics: Animals; Aorta; Benzopyrans; Cromakalim; Cyclopentanes; Dihydropyridines; Dose-Response Relationship, Drug; Endothelins; Guanidines; Hypertension; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Pinacidil; Potassium Channels; Pyridines; Pyrroles; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 1992 |
Effects of SR 44866, a potassium channel opener, on action potentials of rabbit, guinea pig, and human heart fibers.
Topics: Action Potentials; Animals; Benzopyrans; Cromakalim; Dihydropyridines; Electrophysiology; Guinea Pigs; Heart; Heart Atria; Humans; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Papillary Muscles; Potassium Channels; Purkinje Fibers; Pyrroles; Rabbits; Vasodilator Agents | 1991 |
Two different types of potassium channels in human skeletal muscle activated by potassium channel openers.
Topics: Adenosine Triphosphate; Benzopyrans; Cromakalim; Dihydropyridines; Electrophysiology; Glyburide; Humans; Muscles; Picolines; Potassium Channels; Pyrans; Pyrroles | 1990 |
K+ channel openers suppress myotonic activity of human skeletal muscle in vitro.
Topics: Benzopyrans; Cell Membrane Permeability; Cromakalim; Dihydropyridines; Humans; In Vitro Techniques; Microelectrodes; Muscle Contraction; Muscles; Potassium Channels; Pyrroles; Vasodilator Agents | 1990 |
Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR.
Topics: Animals; Benzopyrans; Brimonidine Tartrate; Cromakalim; Decerebrate State; Dihydropyridines; Heart Rate; Hemodynamics; Imidazoles; Male; Potassium Channels; Pyrroles; Quinoxalines; Rats; Rats, Inbred SHR; Regional Blood Flow; Sympathetic Nervous System; Vascular Resistance | 1990 |
[Potassium agonists: regional vasodilator profile in rats].
Topics: Animals; Benzopyrans; Cromakalim; Dihydropyridines; Hemodynamics; Male; Nicardipine; Pyrroles; Rats; Rats, Inbred Strains; Vasodilator Agents | 1989 |
Effects of potassium channel activators on isolated cerebral arteries of large and small diameter in the cat.
Topics: Animals; Benzopyrans; Cats; Cerebral Arteries; Cromakalim; Dihydropyridines; Dose-Response Relationship, Drug; Female; Glyburide; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Potassium Channels; Pyrroles; Uridine Triphosphate; Vasodilator Agents | 1995 |
ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
Topics: Benzopyrans; Cromakalim; Dihydropyridines; Guanidines; Humans; Myocardial Ischemia; Myocardium; Niacinamide; Nicorandil; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Sodium-Potassium-Exchanging ATPase; Vasodilator Agents | 1994 |
3-Methyl-2H-1-benzopyran potassium channel activators.
Topics: Acetylcholine; Animals; Benzopyrans; Coronary Vessels; Membrane Potentials; Molecular Conformation; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels; Pulmonary Artery; Rabbits; Structure-Activity Relationship; Swine | 1991 |
Relaxant activity of 4-amido-3,4-dihydro-2H-1-benzopyran-3-ols and 4-amido-2H-1-benzopyrans on guinea pig isolated trachealis.
Topics: Amides; Animals; Benzopyrans; Bronchodilator Agents; Chemical Phenomena; Chemistry; Cromakalim; Guinea Pigs; Molecular Structure; Muscle Relaxation; Potassium Channels; Pyrroles; Structure-Activity Relationship; Trachea | 1990 |
Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers.
Topics: Animals; Binding Sites; Drug Interactions; Guanidines; Muscle, Smooth, Vascular; Pinacidil; Potassium Channels; Pyridines; Rats; Structure-Activity Relationship; Vasodilator Agents | 1993 |